SecBot SecBot

CLSDQ

Clearside Biomedical, Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001539029 Biotech & Drug Discovery
—
Short interest
95.7K
0.0%
Days to cover
18.1
at average volume
New fund stakes
0
Q2 2025 13F · 0 exits

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2025: 2 added (0 new), 2 trimmed or exited.

  • Short sellersSTEADY

    Short interest 0.0% to 95.7K shares. 18.1 days to cover.

Who's buying

13F· Q2 2025
0
new positions
0
exits
FundMoveSharesValue
STIFEL FINANCIAL CORPADD39,944$32.0K
UBS Group AGTRIM32,513$26.0K
OSAIC HOLDINGS, INC.DOUBLED2,705$2.2K
JPMORGAN CHASE & CONEAR_EXIT840$672.00
UBS Group AGTRIM62,069$57.0K
PRUDENTIAL FINANCIAL INCADD24,400$22.4K
COMMONWEALTH EQUITY SERVICES, LLCDOUBLED22,500$21.0K
BANK OF AMERICA CORP /DE/TRIM1,905$1.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Nov 2025
Recent actions
DateFirmActionRating
Nov 18, 2025Needham
REITERATE
REITERATEHold

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current FY———$0.00
Next Q———$0.00
Next FY———$0.00
Current Q———$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2025 Inst.
STIFEL FINANCIAL CORP — ADD
39,944 shares ($32.0K)
Jun 30, 2025 Inst.
UBS Group AG — TRIM
32,513 shares ($26.0K)

Short side

FINRA· Jun 30, 2026
95,698
shares short
0.0%
vs prior settlement
18.1
days to cover